📰 Treatment Patterns News
Page 5 - Treatment Patterns News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Treatment Patterns. Real-time updates on events, politics, business and more.
May 18, 2022
Longer term follow-up data will be presented from the pivotal CARTITUDE-1 study in patients with relapsed or refractory multiple myeloma, which supported the recent U.S. FDA approval of CARVYKTI
May 16, 2022
/PRNewswire/ -- Before puberty, migraine headaches are equally as common in boys and girls, but following puberty, migraine becomes 2-3 times more common in...
May 12, 2022
/PRNewswire/ -- AbbVie (NYSE: ABBV) will present 46 abstracts across eight types of cancer during the upcoming American Society of Clinical Oncology (ASCO)...
May 9, 2022
Lupus Awareness Month 2022: Advocates for the 5 million people worldwide living with this often-debilitating autoimmune disease set the bar for quality care and better futures for patients.
December 6, 2021
/PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced new data from its hematology pipeline and marketed portfolio to be presented at the 63rd American Society...
December 6, 2021
Press release content from PR Newswire. The AP news staff was not involved in its creation.
November 4, 2021
Sixteen new abstracts to be presented, including the first presentation of data from the Rylaze (asparaginase erwinia chrysanthemi (recombinant)-rywn) Phase 2/3 study that supported U.S. FDA
November 4, 2021
/PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that 16 new data abstracts from across its hematology/oncology development program will...
November 4, 2021
Numerous oral presentations highlighting data for tafasitamab, parsaclisib, ruxolitinib, pemigatinib, itacitinib and ponatinib to be highlighted during the Congress Incyte (Nasdaq:INCY) today announced
November 4, 2021
/PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that 16 new data abstracts from across its hematology/oncology development program will...